Story

Teladoc Stock Plummets 24% on Weak Revenue and Dismal Forecast

ENTHMSVIIDZHZH-TWJAKOHI
Jul 29, 20261 min read
Teladoc Stock Plummets 24% on Weak Revenue and Dismal Forecast

Summary

Teladoc Health (TDOC) shares plunged in after-hours trading after the company reported a Q2 revenue miss and issued a significantly weaker-than-expected forecast for the third quarter and full year.

Text size
Background

Teladoc Health (NYSE: TDOC) shares plummeted nearly 24% in after-hours trading after the virtual healthcare company's second-quarter revenue fell short of expectations and it issued a significantly weakened financial outlook. The dismal forecast erased recent investor optimism and signaled deepening challenges for the telehealth provider.

Earnings and Outlook Disappoint

For the second quarter of 2026, Teladoc reported revenue of $606.9 million, missing the analyst consensus estimate of approximately $615 million, according to Investing.com. While the company's adjusted loss per share of $0.21 was narrower than the anticipated $0.25 loss, this modest beat was completely overshadowed by its forward guidance.

The most damaging element of the report was the company's forecast. Teladoc projected third-quarter revenue in a range of $569 million to $609 million, with the midpoint falling substantially below the consensus analyst expectation of $629 million. The company also lowered its full-year 2026 earnings outlook to a loss of between $1.00 and $0.75 per share, further disappointing investors.

Market Reaction

Sample IUX Markets – In-articleAd

The stock's sharp decline to $6.98 in extended trading marked a dramatic reversal of fortune. Prior to the earnings release, Teladoc shares had accumulated a year-to-date gain of nearly 30%, indicating that investors had been pricing in a recovery that failed to materialize in the latest report. The sell-off was entirely company-specific, as the broader S&P 500 and Nasdaq indexes were nearly flat.

Underlying Business Pressures

The weak results and guidance suggest continued struggles within key business lines, including the company's BetterHelp mental health segment, which has been a focus of investor concern. The telehealth sector also faces a rapidly evolving competitive landscape, with technology giants increasingly entering the virtual care space. Earlier in July, Teladoc shares had already faced pressure after OpenAI announced health-record integration for ChatGPT, highlighting the growing threat from AI-native platforms.

Read next

More on Stocks
Back to latest news

LATEST